Skip to main content

and
  1. Article

    Open Access

    A phase 2 study of carfilzomib, cyclophosphamide and dexamethasone as frontline treatment for transplant-eligible MM with high-risk features (SGH-MM1)

    Yunxin Chen, Sathish Kumar Gopalakrishnan, Melissa Ooi in Blood Cancer Journal (2021)

  2. Article

    Open Access

    High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphoma

    The role of central nervous system (CNS) prophylaxis with high-dose methotrexate (HDMTX) in DLBCL is controversial. In this retrospective study, we evaluated the efficacy of prophylactic HDMTX on isolated CNS ...

    Shin Yeu Ong, Sanjay de Mel, Nicholas Francis Grigoropoulos in Blood Cancer Journal (2021)